These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 28283017
1. Forkhead-box transcription factor 1 affects the apoptosis of natural regulatory T cells by controlling Aven expression. Cai Z, Liu H, Wu X. BMC Immunol; 2017 Mar 10; 18(1):16. PubMed ID: 28283017 [Abstract] [Full Text] [Related]
2. FoxO1 controls the expansion of pre-B cells by regulating the expression of interleukin 7 receptor α chain and its signal pathway. Li Z, Zhang N, Hui F, Zahid D, Zheng W, Xu X, Li W. Immunol Lett; 2019 Dec 10; 216():28-35. PubMed ID: 31545960 [Abstract] [Full Text] [Related]
3. FoxO1 regulates apoptosis induced by asbestos in the MT-2 human T-cell line. Matsuzaki H, Lee S, Maeda M, Kumagai-Takei N, Nishimura Y, Otsuki T. J Immunotoxicol; 2016 Sep 10; 13(5):620-7. PubMed ID: 27042963 [Abstract] [Full Text] [Related]
4. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Luo CT, Liao W, Dadi S, Toure A, Li MO. Nature; 2016 Jan 28; 529(7587):532-6. PubMed ID: 26789248 [Abstract] [Full Text] [Related]
7. Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells. Simonetta F, Chiali A, Cordier C, Urrutia A, Girault I, Bloquet S, Tanchot C, Bourgeois C. Eur J Immunol; 2010 Sep 28; 40(9):2528-38. PubMed ID: 20690182 [Abstract] [Full Text] [Related]
8. Lack of Ikaros cripples expression of Foxo1 and its targets in naive T cells. Agnihotri P, Robertson NM, Umetsu SE, Arakcheeva K, Winandy S. Immunology; 2017 Nov 28; 152(3):494-506. PubMed ID: 28670688 [Abstract] [Full Text] [Related]
10. Inhibition of FOXO1 by small interfering RNA enhances proliferation and inhibits apoptosis of papillary thyroid carcinoma cells via Akt/FOXO1/Bim pathway. Song HM, Song JL, Li DF, Hua KY, Zhao BK, Fang L. Onco Targets Ther; 2015 Nov 28; 8():3565-73. PubMed ID: 26664140 [Abstract] [Full Text] [Related]
14. Ex vivo modulation of the Foxo1 phosphorylation state does not lead to dysfunction of T regulatory cells. Penberthy KK, Buckley MW, Arandjelovic S, Ravichandran K. PLoS One; 2017 Nov 28; 12(3):e0173386. PubMed ID: 28267764 [Abstract] [Full Text] [Related]
16. Quxie Capsule Inhibits Colon Tumor Growth Partially Through Foxo1-Mediated Apoptosis and Immune Modulation. Chen D, Yang Y, Yang P. Integr Cancer Ther; 2019 Nov 28; 18():1534735419846377. PubMed ID: 31030593 [Abstract] [Full Text] [Related]
17. Regulation of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma. Ahn EH. Anticancer Res; 2013 May 28; 33(5):2029-35. PubMed ID: 23645752 [Abstract] [Full Text] [Related]
18. CK2 Controls Th17 and Regulatory T Cell Differentiation Through Inhibition of FoxO1. Gibson SA, Yang W, Yan Z, Qin H, Benveniste EN. J Immunol; 2018 Jul 15; 201(2):383-392. PubMed ID: 29891553 [Abstract] [Full Text] [Related]
19. Marked Reduction in FoxO1 Protein by its Enhanced Proteasomal Degradation in Zfat-deficient Peripheral T-Cells. Iwaihara Y, Ishikura S, Doi K, Tsunoda T, Fujimoto T, Okamura T, Shirasawa S. Anticancer Res; 2015 Aug 15; 35(8):4419-23. PubMed ID: 26168481 [Abstract] [Full Text] [Related]
20. Transcription factor HBP1 is a direct anti-cancer target of transcription factor FOXO1 in invasive oral cancer. Chan CY, Huang SY, Sheu JJ, Roth MM, Chou IT, Lien CH, Lee MF, Huang CY. Oncotarget; 2017 Feb 28; 8(9):14537-14548. PubMed ID: 28099936 [Abstract] [Full Text] [Related] Page: [Next] [New Search]